Zheqi Li

16PUBLICATIONS
97CO-AUTHORS
Molecular targetsSolid tumoursCancer cell biologyGenomics and transcriptomicsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Apr 02, 2026
HER2 Heterogeneous Breast Cancer Models Reveal Novel Therapeutic Targets and Subclonal Dynamics during Evolution to Resistance to HER2-Targeted Therapies.

Marie-Anne Goyette, Christopher Graser, Marco Seehawer

|Mar 27, 2026
Estrogen receptor-positive cell line xenograft models recapitulate metastatic dissemination and endocrine response of invasive lobular breast carcinoma.

Nilgun Tasdemir, Laura Savariau, Julie Scott

|Jun 27, 2025
p95HER2, a truncated form of the HER2 oncoprotein, drives an immunosuppressive program in HER2+ breast cancer that limits trastuzumab deruxtecan efficacy.

Dong Hu, Xiaoshuang Lyu, Zheqi Li

|Jun 02, 2025
KDM4C inhibition blocks tumor growth in basal breast cancer by promoting cathepsin L-mediated histone H3 cleavage.

Zheqi Li, Guillermo Peluffo, Laura E Stevens

|Dec 20, 2024
The EstroGene2.0 database for endocrine therapy response and resistance in breast cancer.

Zheqi Li, Fangyuan Chen, Li Chen

|Nov 22, 2024
Hope for Others: Research Results from the University of Pittsburgh Rapid Autopsy Program for Breast Cancer.

Alexander Chih-Chieh Chang, Marija Balic, Tanner Bartholow

Pageof 3

Frequent Collaborators

10 joint publications

Adrian V Lee

6 joint publications

Steffi Oesterreich

6 joint publications

Kornelia Polyak

5 joint publications

George Tseng